Cambridge Investment Research Advisors’s NRX Pharmaceuticals, Inc. Warrant NRXPW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$9K	–	3164
2022 Q1	$9K	Sell	10,000 -19,450	-66%	-$17.5K	﹤0.01%	3144
2021 Q4	$54K	Buy	29,450 +12,480	+74%	+$22.9K	﹤0.01%	3098
2021 Q3	$81K	Buy	+16,970	New	+$81K	﹤0.01%	2982